CD274 targeting antisense oligonucleotide (Stoke Therapeutics)

N/A

Report date: 2025/01/26 19:30:52
NME

Base Information

Drug NameCD274 targeting antisense oligonucleotide (Stoke Therapeutics)
Drug Alias NameCD274 gene stimulator (Stoke Therapeutics)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionProgrammed death-ligand 1 agonists
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStoke Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesStoke Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsEye Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A